Opgen Inc (CFOR) — 8-K Filings

8-K Filings (23)

• Opgen Inc. Files 8-K: Material Agreement, Equity Sales, Officer Changes — Dec 23, 2025 Risk: medium
  On December 17, 2025, Opgen Inc. entered into a material definitive agreement. The company also reported on unregistered sales of equity securities and changes
• OPGEN INC. Reports Director, Officer, and Compensation Changes — Dec 5, 2025 Risk: medium
  On December 1, 2025, OPGEN INC. filed an 8-K report detailing changes in its board of directors and executive officers, including the election of new directors
• OpGen Inc. Reports Board and Executive Changes — Jul 22, 2025 Risk: medium
  On July 17, 2025, OpGen, Inc. reported a change in its board of directors and executive officers. Specifically, the company announced the departure of certain d
• OpGen Inc. Files 8-K for Material Agreement — May 29, 2025 Risk: low
  OpGen, Inc. filed an 8-K on October 2, 2024, reporting the entry into a material definitive agreement and filing financial statements and exhibits. The filing d
• OpGen Inc. Faces Delisting Concerns — Dec 27, 2024 Risk: high
  OpGen, Inc. filed an 8-K on December 27, 2024, reporting a notice of delisting or failure to satisfy continued listing rules. The filing indicates a potential t
• OpGen Inc. Reports Board and Officer Changes — Dec 6, 2024 Risk: medium
  On December 4, 2024, OpGen, Inc. filed an 8-K report detailing changes in its board of directors and executive officers. The filing includes information on the
• OpGen Inc. Files 8-K with Material Agreement Details — Oct 9, 2024 Risk: medium
  On October 3, 2024, OpGen, Inc. entered into a material definitive agreement. The company also reported on unregistered sales of equity securities and filed fin
• OpGen Inc. Files 8-K: Agreements, Delisting Notice, Equity Sales — Aug 22, 2024 Risk: high
  On August 16, 2024, OpGen, Inc. filed an 8-K report detailing several significant events. These include the entry into and termination of material definitive ag
• OpGen Inc. Reports Board and Executive Changes — Aug 15, 2024 Risk: medium
  On August 9, 2024, OpGen, Inc. filed an 8-K report detailing changes in its board of directors and executive compensation. The filing indicates a shift in leade
• OpGen Inc. Files 8-K: Equity Sales, Control Change, Officer/Director Updates — Aug 2, 2024 Risk: medium
  On July 29, 2024, OpGen, Inc. filed an 8-K report detailing several significant events. These include unregistered sales of equity securities, a change in contr
• OpGen Inc. Faces Delisting Concerns — Jun 11, 2024 Risk: high
  OpGen, Inc. filed an 8-K on June 11, 2024, reporting a notice of delisting or failure to satisfy a continued listing rule or standard. The company's principal e
• OpGen Inc. Files 8-K on Delisting Notice — Jun 3, 2024 Risk: high
  OpGen, Inc. filed an 8-K on May 29, 2024, reporting a notice of delisting or failure to satisfy a continued listing rule or standard, and a transfer of listing.
• OpGen Inc. Faces Delisting Notice — May 24, 2024 Risk: high
  OpGen, Inc. filed an 8-K on May 24, 2024, reporting a notice of delisting or failure to satisfy continued listing rules. The company's principal executive offic
• OpGen Inc. Files 8-K: Material Agreements & Bylaw Changes — May 22, 2024 Risk: medium
  On May 16, 2024, OpGen, Inc. entered into a material definitive agreement, the details of which are not fully disclosed in this filing. The company also made mo
• OpGen Inc. Files 8-K with Key Corporate Updates — May 14, 2024 Risk: medium
  On May 9, 2024, OpGen, Inc. filed an 8-K report detailing several significant events. These include material modifications to the rights of security holders, am
• OpGen, Inc. Files 8-K: Material Agreement and Other Events — Apr 29, 2024 Risk: medium
  On April 23, 2024, OpGen, Inc. entered into a Material Definitive Agreement, the details of which are not fully disclosed in this filing. The company also repor
• OpGen Inc. Reports Change in Certifying Accountant — Apr 25, 2024 Risk: low
  OpGen, Inc. filed an 8-K on April 25, 2024, reporting changes in its certifying accountant. The company, incorporated in Delaware, is located at 9717 Key West A
• OpGen Inc. Faces Delisting Concerns — Apr 23, 2024 Risk: high
  OpGen, Inc. filed an 8-K on April 23, 2024, reporting a notice of delisting or failure to satisfy a continued listing rule or standard. The company's principal
• Opgen Inc. Reports Board Changes and Officer Compensation Updates — Apr 17, 2024 Risk: medium
  On April 11, 2024, Opgen Inc. filed an 8-K report detailing changes in its board of directors and executive compensation. The filing indicates the election of n
• OpGen, Inc. Files 8-K Detailing Acquisition and Corporate Changes — Mar 29, 2024 Risk: medium
  On March 25, 2024, OpGen, Inc. entered into a material definitive agreement related to its acquisition by Invivoscribe, Inc. The filing also details unregistere
• OpGen Files 8-K for Undisclosed "Other Events" — Feb 13, 2024 Risk: medium
  The 8-K filing by OpGen, Inc. (CIK: 0001293818) on February 13, 2024, reports an event that occurred on February 9, 2024, under Item 8.01, "Other Events," and I
• OpGen Sells $1.5M in Stock & Warrants in Private Placement — Feb 8, 2024 Risk: high
  OpGen, Inc. entered into a securities purchase agreement on February 7, 2024, to sell 1,000,000 shares of its common stock at a price of $1.50 per share, totali
• OpGen Reports Officer Compensatory Arrangement Changes — Jan 9, 2024
  OpGen, Inc. filed an 8-K on January 9, 2024, reporting an event that occurred on January 4, 2024, related to changes in compensatory arrangements for certain of

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX